000 01446 a2200433 4500
005 20250518082200.0
264 0 _c20201006
008 202010s 0 0 eng d
022 _a1095-6859
024 7 _a10.1016/j.ygyno.2020.01.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEngerud, Hilde
245 0 0 _aHigh degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer.
_h[electronic resource]
260 _bGynecologic oncology
_c04 2020
300 _a260-267 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aB7-H1 Antigen
_xbiosynthesis
650 0 4 _aEndometrial Neoplasms
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasm Staging
650 0 4 _aPrognosis
650 0 4 _aProgrammed Cell Death 1 Receptor
_xbiosynthesis
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aTranscriptome
700 1 _aBerg, Hege F
700 1 _aMyrvold, Madeleine
700 1 _aHalle, Mari K
700 1 _aBjorge, Line
700 1 _aHaldorsen, Ingfrid S
700 1 _aHoivik, Erling A
700 1 _aTrovik, Jone
700 1 _aKrakstad, Camilla
773 0 _tGynecologic oncology
_gvol. 157
_gno. 1
_gp. 260-267
856 4 0 _uhttps://doi.org/10.1016/j.ygyno.2020.01.020
_zAvailable from publisher's website
999 _c30553395
_d30553395